I
Immaculata Xess
Researcher at All India Institute of Medical Sciences
Publications - 164
Citations - 4097
Immaculata Xess is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Medicine & Mucormycosis. The author has an hindex of 27, co-authored 131 publications receiving 2969 citations. Previous affiliations of Immaculata Xess include AIIMS, New Delhi.
Papers
More filters
Journal ArticleDOI
Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida
Aijaz Ahmad,Amber Khan,Feroz Akhtar,Snowber Yousuf,Immaculata Xess,Luqman A. Khan,Nikhat Manzoor +6 more
TL;DR: Thymol and carvacrol show strong fungicidal effect against all of the Candida isolates and the mechanisms of action of these natural isopropyl cresols appear to originate from the inhibition of ergosterol biosynthesis and the disruption of membrane integrity.
Journal ArticleDOI
Incidence, characteristics and outcome of ICU-acquired candidemia in India
Arunaloke Chakrabarti,Prashant Sood,Shivaprakash M Rudramurthy,Sharon C.-A. Chen,Harsimran Kaur,Malini R. Capoor,Deepinder Chhina,Ratna Rao,Vandana Kalwaje Eshwara,Immaculata Xess,Anupama Kindo,P. Umabala,Jayanthi Savio,Atul Patel,Ujjwayini Ray,Sangeetha Mohan,Ranganathan N Iyer,Jagdish Chander,Anita Arora,Raman Sardana,Indranil Roy,B. Appalaraju,Ajanta Sharma,Anjali Shetty,Neelam Khanna,Rungmei S. K. Marak,Sanjay Biswas,Shukla Das,Belgode Narasimha Harish,Sangeeta Joshi,Deepak Kumar Mendiratta +30 more
TL;DR: A high burden of candidemia in Indian ICUs, early onset after ICU admission, higher risk despite less severe physiology score at admission and a vast spectrum of agents causing the disease with predominance of C. tropicalis is highlighted.
Journal ArticleDOI
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Atul Patel,Ritesh Agarwal,Shivaprakash M Rudramurthy,Manoj Shevkani,Immaculata Xess,Ratna Sharma,Jayanthi Savio,Nandini Sethuraman,Surabhi Madan,Prakash Shastri,Deepak Thangaraju,Rungmei S. K. Marak,Karuna Tadepalli,Pratik Savaj,Ayesha Sunavala,Neha Gupta,Tanu Singhal,Valliappan Muthu,Arunaloke Chakrabarti +18 more
TL;DR: In this paper, the authors conducted a multicenter retrospective study across India to evaluate epidemiology and outcomes among cases of coronavirus disease (COVID-19)-associated mucormycosis (CAM).
Journal ArticleDOI
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India
Atul Patel,Atul Patel,Harsimran Kaur,Immaculata Xess,Joy Sarojini Michael,Jayanthi Savio,Shivaprakash M Rudramurthy,Rakesh Singh,Prakash Shastri,P. Umabala,Raman Sardana,Anupama Kindo,Malini R. Capoor,Sangeetha Mohan,Valliappan Muthu,Ritesh Agarwal,Arunaloke Chakrabarti +16 more
TL;DR: Diabetes mellitus was the dominant predisposing factor in all forms of mucormycosis and combined surgical and medical management was associated with better outcomes.
Journal ArticleDOI
A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment
Hariprasath Prakash,Anup K. Ghosh,Shivaprakash M Rudramurthy,Pankaj Singh,Immaculata Xess,Jayanthi Savio,Umabala Pamidimukkala,Joseph Jillwin,Subhash Varma,Ashim Das,Naresh K. Panda,Surjit Singh,Amanjit Bal,Arunaloke Chakrabarti +13 more
TL;DR: Higher number of mucormycosis cases in uncontrolled diabetics of north India and emergence of R. microsporus and R. homothallicus across India causing the disease are highlighted.